Unique human CD133+ leukemia cell line and its modulation towards a mesenchymal phenotype by FGF2 and TGFβ1<FNR></FNR><FN>Maria Bodo and Tiziano Baroni have contributed equally to this study. </FN>.

MLA

Bodo, Maria, et al. “Unique Human CD133+ Leukemia Cell Line and Its Modulation towards a Mesenchymal Phenotype by FGF2 and TGFβ1Maria Bodo and Tiziano Baroni Have Contributed Equally to This Study. .” Journal of Cellular Physiology, vol. 206, no. 3, Mar. 2006, pp. 682–92. EBSCOhost, https://doi.org/10.1002/jcp.20517.

APA

Bodo, M., Baroni, T., Bellucci, C., Lilli, C., De Ioanni, M., Bonifacio, E., Moretti, L., Becchetti, E., Bellocchio, S., Delfini, C., Lumare, E., & Tabilio, A. (2006). Unique human CD133+ leukemia cell line and its modulation towards a mesenchymal phenotype by FGF2 and TGFβ1Maria Bodo and Tiziano Baroni have contributed equally to this study. . Journal of Cellular Physiology, 206(3), 682–692. https://doi.org/10.1002/jcp.20517

Chicago

Bodo, Maria, Tiziano Baroni, Catia Bellucci, Cinzia Lilli, Maria De Ioanni, Elisabetta Bonifacio, Lorenzo Moretti, et al. 2006. “Unique Human CD133+ Leukemia Cell Line and Its Modulation towards a Mesenchymal Phenotype by FGF2 and TGFβ1Maria Bodo and Tiziano Baroni Have Contributed Equally to This Study. .” Journal of Cellular Physiology 206 (3): 682–92. doi:10.1002/jcp.20517.